Immunogenicity and Safety of Monovalent and Bivalent SARS-CoV-2 Variant Adapted RBD-based Protein Booster Vaccines in Adults Previously Immunized with Different Vaccine Platforms: A Phase II/III, Randomized Clinical Trial.
Gonzalo Perez Marc,Lorena M Coria,Ana Ceballos,Juan Manuel Rodriguez,Mónica E Lombardo,Laura Bruno,Federico Páez Córdoba,Clara G Fascetto Cassero,Melina Salvatori,Mayra Rios Medrano,Fabiana Fulgenzi,María F Alzogaray,Analía Mykietiuk,Ignacio Leandro Uriarte,Nicolás Itcovici,Tomás Smith Casabella,Gonzalo Corral,Miriam Bruno,Oscar Roldán,Sebastián A Núñez,Florencia Cahn,Gustavo A Yerino,Alejandra Bianchi,Virginia Braem,Analía Christmann,Santiago Corradetti,Martín C Darraidou,Lucila Di Nunzio,Tatiana Estrada,Rocío López Castelo,Carla Marchionatti,Lucila Pitocco,Virgina Trias Uriarte,Cristian Wood,Romina Zadoff,Florencia Bues,Rosa M Garrido,Emanuele Montomoli,Alessandro Manenti,Laboratorio Pablo Cassará group for ARVAC,Agostina Demaría,Lineia Prado,Celeste Pueblas Castro,Lucas Saposnik,Jorge Geffner,Federico Montes de Oca,Julio C Vega,Juan Fló,Pablo Bonvehí,Jorge Cassará,Karina A Pasquevich,Juliana Cassataro
Vaccine（2025）
Cited0|Views2
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined
